Rocio Egoávil-Espejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rocio Egoávil-Espejo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Joaquim Ruiz
Universidad Científica del Sur
2 shared publications - Maria Jesus Pons
Universidad Científica del Sur
2 shared publications - Barbara Ymaña
Grupo de Investigación en Dinámicas y Epidemiología de la Resistencia a Antimicrobianos—“One Health”, Universidad Científica del Sur , Antigua Panamericana Sur Km 19, Villa El Salvador, 15067 Lima
1 shared publication - Beatriz Rojo-Bezares
Area de Microbiología Molecular, Centro de Investigación Biomédica de La Rioja
1 shared publication - Carla Andrea Alonso
Departamento de Diagnóstico Biomédico, Laboratorio de Microbiología, Hospital Universitario San Pedro, Logroño, Spain
1 shared publication - Carmen Valera-Krumdieck
Servicio de Patología Clínica, área de Microbiología, Hospital María Auxiliadora, Lima, Perú
1 shared publication
Latest Publications
- Open Access
- 30 December 2024
- Published by Universidad Cientifica del Sur in South Health
- Vol. 1, e008
Determinación e interpretación de la sensibilidad a cefiderocol
Cefiderocol is a new antibacterial agent active against Gram-negative bacteria of clinical interest. Cefiderocol passively penetrates the bacteria through porins and actively through iron uptake systems. This peculiarity results in the need to perform slight modifications when performing minimal inhibitory concentration assays. Thus, it is needed a cation-free culture media, and a thin grown is unconsidered.
- 30 December 2024
- Published by Universidad Cientifica del Sur in South Health
- Vol. 1, e008
Open AccessDeterminación e interpretación de la sensibilidad a cefiderocol
Cefiderocol is a new antibacterial agent active against Gram-negative bacteria of clinical interest. Cefiderocol passively penetrates the bacteria through porins and actively through iron uptake systems. This peculiarity results in the need to perform slight modifications when performing minimal inhibitory concentration assays. Thus, it is needed a cation-free culture media, and a thin grown is unconsidered.
- Open Access
- 25 September 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (3) , 377-8
Primera descripción de infección por el subcomplejo Acinetobacter pittii / lactucae en el Perú
- 25 September 2023
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 40 (3) , 377-8
Open AccessPrimera descripción de infección por el subcomplejo Acinetobacter pittii / lactucae en el Perú
- Open Access
- 14 October 2021
- Published by MDPI AG in Micromachines
- Vol. 12 (10) , 1245
Systematic Review: Microfluidics and Plasmodium
Malaria affects 228 million people worldwide each year, causing severe disease and worsening the conditions of already vulnerable populations. In this review, we explore how malaria has been detected in the past and how it can be detected in the future. Our primary focus is on finding new directions for low-cost diagnostic methods that unspecialized personnel can apply in situ. Through this review, we show that microfluidic devices can help pre-concentrate samples of blood infected with malaria to facilitate the diagnosis. Importantly, these devices can be made cheaply and be readily deployed in remote locations.
- 14 October 2021
- Published by MDPI AG in Micromachines
- Vol. 12 (10) , 1245
Open AccessSystematic Review: Microfluidics and Plasmodium
Malaria affects 228 million people worldwide each year, causing severe disease and worsening the conditions of already vulnerable populations. In this review, we explore how malaria has been detected in the past and how it can be detected in the future. Our primary focus is on finding new directions for low-cost diagnostic methods that unspecialized personnel can apply in situ. Through this review, we show that microfluidic devices can help pre-concentrate samples of blood infected with malaria to facilitate the diagnosis. Importantly, these devices can be made cheaply and be readily deployed in remote locations.